AMBS | Amarantus and MJFF Disagreement Could Cost Big

AMBS Stock, Amarantus BioSciences Inc.Although Gerald Commissiong, President & CEO of Amarantus BioSciences Inc. (AMBS), wasn’t the best Running Back while at Stanford, the PR “fumble” could be costly. Although they timed the good news with Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (RBCC), to come out before the market opened, they waited til the final whistle blew to close the markets ...

Continue Reading →
0

AMBS | Hats Off To Amarantus Biosciences Shareholders

AMBS Stock, Amarantus BioSciences Inc. Two weeks ago, Amarantus BioSciences Inc. (AMBS) issued a PR announcing positive behavioural efficacy data for their fight against Parkinson’s disease. Since then, when just 3 million shares were trading at a high of 0.0065, AMBS stock price has exploded exponentially gaining 764% in the process. Had it not been for patience and prior knowledge that any good ...

Continue Reading →
0